Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Paal
Alan P. Paal, New Franken, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090101671 | PUMPING DISPENSER - A device for dispensing a flowable material is disclosed. The device includes a container holding the flowable material therein and a pumping assembly attached to the container. The pumping assembly includes a pump and a placard portion configured for displaying viewable information thereon associated with the flowable material. | 04-23-2009 |
| 20090114669 | Sheet Product Dispenser - A nozzle for dispensing sheet product is disclosed. The nozzle includes a base portion having an inner periphery and an outer periphery and oriented substantially perpendicular to a dispense direction of the sheet product. A sloping portion of the nozzle is disposed proximate a center of the base portion. The sloping portion extends from the inner periphery of the base portion toward the center in the dispense direction and terminates at an edge defining an opening of the nozzle. The nozzle further includes a lip portion disposed about the outer periphery of the base portion, and a retention feature extending from the lip portion. | 05-07-2009 |
| 20100072227 | INTERCHANGEABLE ACCESS DEVICE FOR A DISPENSER - An interchangeable access device for a dispenser is provided. The interchangeable access devices include a push-button device and a keyed-device. Each of the access devices includes a retaining feature that allows the access device to be removably coupled to a dispenser cover. The access devices cooperate with a latch member to disengage the latch member from a catch coupled to a back-housing. The access devices may be removed and interchanged by a dispenser operator to reflect changes in the application environment. | 03-25-2010 |
Jürgen Paal, Bad Homburg V.d.h. DE
| Patent application number | Description | Published |
|---|---|---|
| 20100317565 | Novel Peptides and Their Use for the Treatment of Edema - The invention relates to novel peptides, which can be used for the production of pharmaceutical compositions. These pharmaceutical compositions can be used for the treatment of edema, in particular pulmonary edema. | 12-16-2010 |
Jürgen Paal, Bad Homburg V.d.h. DE
| Patent application number | Description | Published |
|---|---|---|
| 20100317565 | Novel Peptides and Their Use for the Treatment of Edema - The invention relates to novel peptides, which can be used for the production of pharmaceutical compositions. These pharmaceutical compositions can be used for the treatment of edema, in particular pulmonary edema. | 12-16-2010 |
Krisztina Paal, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20100076008 | Pharmaceutical compositions containing plasma protein - The invention is related to water-soluble products and pharmaceutical formulations in solid or liquid form mainly for parenteral use. They consist of or comprise a therapeutically active substance (having low aqueous solubility and a substantial binding affinity to plasma proteins) and a plasma protein fraction in controlled aggregation state, whereby the said active substance and the said protein fraction are bound to each other by way of non-covalent bonds. It also covers processes for the preparation of the product and pharmaceutical formulation by dissolving the water-insoluble active substance in a water-miscible, pharmaceutically acceptable solvent, combining said solution with the aqueous solution of a plasma protein fraction in controlled aggregation state whereby a true solution is obtained containing the said active substance and the said protein fraction bound together by way of non-covalent bonds. Optionally a further pharmaceutically acceptable auxiliary additive—such as a protein aggregation controller and/or a stabilizer—may be present. The organic solvent is eliminated by dialysing, ultrafiltrating, diafiltrating and/or lyophilising. The solid products consisting of the active substance and the protein are also protected. On optional dissolution in water clear, liquid compositions are obtained suitable for direct parenteral or other administration. Method of treatment is also covered. A series of water-insoluble substances is enlisted with appropriate protein fractions to be used. | 03-25-2010 |